Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Litwin

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Cancer Investigation|March 16, 2006
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancyCorey J Langer, Karen Duffy, Eric M Horwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinomaYu-Ning Wong, Samuel Litwin, David Vaughn, et al.
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
NPJ Genomic Medicine|November 24, 2023
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancerIlya G Serebriiskii, Valerii A Pavlov, Grigorii V Andrianov, et al.
Cancer Research|March 17, 2007
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancerSeiji Mabuchi, Deborah A Altomare, Denise C Connolly, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.
Cancer|October 30, 2003
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase NetworkNaomi B Haas, Bruce J Giantonio, Samuel Litwin, et al.
Cancer Research|May 31, 2002
Cyclin D1 is a candidate oncogene in cutaneous melanomaEdward R Sauter, Un-Cheol Yeo, Andrea von Stemm, et al.
The Oncologist|March 29, 2014
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcomaElizabeth R Plimack, Tingting Tan, Yu-Ning Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boostGary M Freedman, Penny R Anderson, Lori J Goldstein, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Cancer Investigation|March 16, 2006
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancyCorey J Langer, Karen Duffy, Eric M Horwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2012
Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinomaYu-Ning Wong, Samuel Litwin, David Vaughn, et al.
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
NPJ Genomic Medicine|November 24, 2023
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancerIlya G Serebriiskii, Valerii A Pavlov, Grigorii V Andrianov, et al.
Cancer Research|March 17, 2007
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancerSeiji Mabuchi, Deborah A Altomare, Denise C Connolly, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.
Cancer|October 30, 2003
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase NetworkNaomi B Haas, Bruce J Giantonio, Samuel Litwin, et al.
Cancer Research|May 31, 2002
Cyclin D1 is a candidate oncogene in cutaneous melanomaEdward R Sauter, Un-Cheol Yeo, Andrea von Stemm, et al.
The Oncologist|March 29, 2014
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcomaElizabeth R Plimack, Tingting Tan, Yu-Ning Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boostGary M Freedman, Penny R Anderson, Lori J Goldstein, et al.
Pageof 8